Titre : Radiothérapie

Radiothérapie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Immunization Programs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Radiothérapie : Questions médicales les plus fréquentes", "headline": "Radiothérapie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Radiothérapie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-03", "dateModified": "2025-04-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Radiothérapie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Thérapeutique", "url": "https://questionsmedicales.fr/mesh/D013812", "about": { "@type": "MedicalCondition", "name": "Thérapeutique", "code": { "@type": "MedicalCode", "code": "D013812", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Curiethérapie", "alternateName": "Brachytherapy", "url": "https://questionsmedicales.fr/mesh/D001918", "about": { "@type": "MedicalCondition", "name": "Curiethérapie", "code": { "@type": "MedicalCode", "code": "D001918", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.150" } } }, { "@type": "MedicalWebPage", "name": "Chimioradiothérapie", "alternateName": "Chemoradiotherapy", "url": "https://questionsmedicales.fr/mesh/D059248", "about": { "@type": "MedicalCondition", "name": "Chimioradiothérapie", "code": { "@type": "MedicalCode", "code": "D059248", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.160" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chimioradiothérapie adjuvante", "alternateName": "Chemoradiotherapy, Adjuvant", "url": "https://questionsmedicales.fr/mesh/D059186", "about": { "@type": "MedicalCondition", "name": "Chimioradiothérapie adjuvante", "code": { "@type": "MedicalCode", "code": "D059186", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.160.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Irradiation crânienne", "alternateName": "Cranial Irradiation", "url": "https://questionsmedicales.fr/mesh/D016371", "about": { "@type": "MedicalCondition", "name": "Irradiation crânienne", "code": { "@type": "MedicalCode", "code": "D016371", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.190" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Irradiation hypophysaire", "alternateName": "Pituitary Irradiation", "url": "https://questionsmedicales.fr/mesh/D010910", "about": { "@type": "MedicalCondition", "name": "Irradiation hypophysaire", "code": { "@type": "MedicalCode", "code": "D010910", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.190.600" } } } ] }, { "@type": "MedicalWebPage", "name": "Irradiation craniospinale", "alternateName": "Craniospinal Irradiation", "url": "https://questionsmedicales.fr/mesh/D061888", "about": { "@type": "MedicalCondition", "name": "Irradiation craniospinale", "code": { "@type": "MedicalCode", "code": "D061888", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.230" } } }, { "@type": "MedicalWebPage", "name": "Radiothérapie par ions lourds", "alternateName": "Heavy Ion Radiotherapy", "url": "https://questionsmedicales.fr/mesh/D063193", "about": { "@type": "MedicalCondition", "name": "Radiothérapie par ions lourds", "code": { "@type": "MedicalCode", "code": "D063193", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Protonthérapie", "alternateName": "Proton Therapy", "url": "https://questionsmedicales.fr/mesh/D061766", "about": { "@type": "MedicalCondition", "name": "Protonthérapie", "code": { "@type": "MedicalCode", "code": "D061766", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.250.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Irradiation hémicorporelle", "alternateName": "Hemibody Irradiation", "url": "https://questionsmedicales.fr/mesh/D017619", "about": { "@type": "MedicalCondition", "name": "Irradiation hémicorporelle", "code": { "@type": "MedicalCode", "code": "D017619", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.270" } } }, { "@type": "MedicalWebPage", "name": "Irradiation ganglionnaire", "alternateName": "Lymphatic Irradiation", "url": "https://questionsmedicales.fr/mesh/D015182", "about": { "@type": "MedicalCondition", "name": "Irradiation ganglionnaire", "code": { "@type": "MedicalCode", "code": "D015182", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.350" } } }, { "@type": "MedicalWebPage", "name": "Radioimmunothérapie", "alternateName": "Radioimmunotherapy", "url": "https://questionsmedicales.fr/mesh/D016499", "about": { "@type": "MedicalCondition", "name": "Radioimmunothérapie", "code": { "@type": "MedicalCode", "code": "D016499", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.520" } } }, { "@type": "MedicalWebPage", "name": "Radiothérapie adjuvante", "alternateName": "Radiotherapy, Adjuvant", "url": "https://questionsmedicales.fr/mesh/D018714", "about": { "@type": "MedicalCondition", "name": "Radiothérapie adjuvante", "code": { "@type": "MedicalCode", "code": "D018714", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.600" } } }, { "@type": "MedicalWebPage", "name": "Dosimétrie en radiothérapie", "alternateName": "Radiotherapy Dosage", "url": "https://questionsmedicales.fr/mesh/D011879", "about": { "@type": "MedicalCondition", "name": "Dosimétrie en radiothérapie", "code": { "@type": "MedicalCode", "code": "D011879", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.639" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Fractionnement de la dose d'irradiation", "alternateName": "Dose Fractionation, Radiation", "url": "https://questionsmedicales.fr/mesh/D019583", "about": { "@type": "MedicalCondition", "name": "Fractionnement de la dose d'irradiation", "code": { "@type": "MedicalCode", "code": "D019583", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.639.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hypofractionnement de dose", "alternateName": "Radiation Dose Hypofractionation", "url": "https://questionsmedicales.fr/mesh/D000069473", "about": { "@type": "MedicalCondition", "name": "Hypofractionnement de dose", "code": { "@type": "MedicalCode", "code": "D000069473", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.639.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Hypofractionnement de dose", "alternateName": "Radiation Dose Hypofractionation", "url": "https://questionsmedicales.fr/mesh/D000069473", "about": { "@type": "MedicalCondition", "name": "Hypofractionnement de dose", "code": { "@type": "MedicalCode", "code": "D000069473", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.639.200.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Radiothérapie de haute énergie", "alternateName": "Radiotherapy, High-Energy", "url": "https://questionsmedicales.fr/mesh/D011882", "about": { "@type": "MedicalCondition", "name": "Radiothérapie de haute énergie", "code": { "@type": "MedicalCode", "code": "D011882", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.722" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thérapie par capture de neutrons", "alternateName": "Neutron Capture Therapy", "url": "https://questionsmedicales.fr/mesh/D017247", "about": { "@type": "MedicalCondition", "name": "Thérapie par capture de neutrons", "code": { "@type": "MedicalCode", "code": "D017247", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.722.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thérapie par capture de neutrons par le bore", "alternateName": "Boron Neutron Capture Therapy", "url": "https://questionsmedicales.fr/mesh/D016754", "about": { "@type": "MedicalCondition", "name": "Thérapie par capture de neutrons par le bore", "code": { "@type": "MedicalCode", "code": "D016754", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.722.500.100" } } } ] }, { "@type": "MedicalWebPage", "name": "Thérapie par capture de neutrons par le bore", "alternateName": "Boron Neutron Capture Therapy", "url": "https://questionsmedicales.fr/mesh/D016754", "about": { "@type": "MedicalCondition", "name": "Thérapie par capture de neutrons par le bore", "code": { "@type": "MedicalCode", "code": "D016754", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.722.500.100" } } }, { "@type": "MedicalWebPage", "name": "Télégammathérapie", "alternateName": "Radioisotope Teletherapy", "url": "https://questionsmedicales.fr/mesh/D011867", "about": { "@type": "MedicalCondition", "name": "Télégammathérapie", "code": { "@type": "MedicalCode", "code": "D011867", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.722.820" } } } ] }, { "@type": "MedicalWebPage", "name": "Radiothérapie guidée par l'image", "alternateName": "Radiotherapy, Image-Guided", "url": "https://questionsmedicales.fr/mesh/D061089", "about": { "@type": "MedicalCondition", "name": "Radiothérapie guidée par l'image", "code": { "@type": "MedicalCode", "code": "D061089", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.768" } } }, { "@type": "MedicalWebPage", "name": "Radiothérapie X", "alternateName": "X-Ray Therapy", "url": "https://questionsmedicales.fr/mesh/D014964", "about": { "@type": "MedicalCondition", "name": "Radiothérapie X", "code": { "@type": "MedicalCode", "code": "D014964", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.815.907" } } } ], "about": { "@type": "MedicalCondition", "name": "Radiothérapie", "alternateName": "Radiotherapy", "code": { "@type": "MedicalCode", "code": "D011878", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "David R Raleigh", "url": "https://questionsmedicales.fr/author/David%20R%20Raleigh", "affiliation": { "@type": "Organization", "name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu." } }, { "@type": "Person", "name": "Baolin Qu", "url": "https://questionsmedicales.fr/author/Baolin%20Qu", "affiliation": { "@type": "Organization", "name": "Precision Medical Advanced Innovation Center, Beijing University of Aeronautics and Astronautics, Beijing, 100083." } }, { "@type": "Person", "name": "Gustavo Arruda Viani", "url": "https://questionsmedicales.fr/author/Gustavo%20Arruda%20Viani", "affiliation": { "@type": "Organization", "name": "Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil." } }, { "@type": "Person", "name": "P A Coucke", "url": "https://questionsmedicales.fr/author/P%20A%20Coucke", "affiliation": { "@type": "Organization", "name": "Service de Radiothérapie, CHU Liège, Belgique." } }, { "@type": "Person", "name": "William C Chen", "url": "https://questionsmedicales.fr/author/William%20C%20Chen", "affiliation": { "@type": "Organization", "name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Weighted capitation incentive (Previne Brasil Program): impacts on the evolution of the population register in PHC.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/37672462", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1413-81232023289.20142022" } }, { "@type": "ScholarlyArticle", "name": "Programmed cell death-1 blockade therapy in melanoma: Resistance mechanisms and combination strategies.", "datePublished": "2023-01-24", "url": "https://questionsmedicales.fr/article/36645031", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/exd.14750" } }, { "@type": "ScholarlyArticle", "name": "Formative evaluation of an exercise training program for persons with multiple sclerosis who are wheelchair users.", "datePublished": "2023-01-21", "url": "https://questionsmedicales.fr/article/36696872", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.evalprogplan.2023.102243" } }, { "@type": "ScholarlyArticle", "name": "Comprehensive Implementation of Shared Decision Making in a Neuromedical Center Using the SHARE TO CARE Program.", "datePublished": "2023-01-13", "url": "https://questionsmedicales.fr/article/36660043", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/PPA.S388432" } }, { "@type": "ScholarlyArticle", "name": "Visualization and Quantification of the Association Between Breast Cancer and Cholesterol in the All of Us Research Program.", "datePublished": "2023-01-12", "url": "https://questionsmedicales.fr/article/36654923", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/11769351221144132" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Thérapeutique", "item": "https://questionsmedicales.fr/mesh/D013812" }, { "@type": "ListItem", "position": 3, "name": "Radiothérapie", "item": "https://questionsmedicales.fr/mesh/D011878" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Radiothérapie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Radiothérapie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Radiothérapie", "description": "Comment la radiothérapie est-elle diagnostiquée ?\nQuels examens précèdent la radiothérapie ?\nQui détermine le besoin de radiothérapie ?\nQuels types de cancers nécessitent la radiothérapie ?\nLa radiothérapie est-elle utilisée en prévention ?", "url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Radiothérapie", "description": "Quels symptômes peuvent apparaître après la radiothérapie ?\nLa radiothérapie cause-t-elle des nausées ?\nY a-t-il des symptômes à long terme ?\nComment gérer la fatigue liée à la radiothérapie ?\nLa radiothérapie affecte-t-elle l'appétit ?", "url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Radiothérapie", "description": "La radiothérapie peut-elle prévenir le cancer ?\nQuels modes de vie aident à prévenir le cancer ?\nLes dépistages aident-ils à éviter la radiothérapie ?\nLes vaccins peuvent-ils prévenir certains cancers ?\nLe stress influence-t-il le cancer ?", "url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Radiothérapie", "description": "Quels types de radiothérapie existent ?\nLa radiothérapie est-elle combinée à d'autres traitements ?\nCombien de séances de radiothérapie sont nécessaires ?\nLa radiothérapie est-elle douloureuse ?\nComment se déroule une séance de radiothérapie ?", "url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Radiothérapie", "description": "Quelles sont les complications possibles de la radiothérapie ?\nLa radiothérapie peut-elle causer des cancers secondaires ?\nComment prévenir les complications de la radiothérapie ?\nLes complications varient-elles selon le type de cancer ?\nQuels soins sont nécessaires après la radiothérapie ?", "url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Radiothérapie", "description": "Quels sont les facteurs de risque pour le cancer traité par radiothérapie ?\nL'âge influence-t-il le besoin de radiothérapie ?\nLes antécédents médicaux influencent-ils la radiothérapie ?\nLe sexe joue-t-il un rôle dans le traitement par radiothérapie ?\nL'alimentation affecte-t-elle le risque de cancer ?", "url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment la radiothérapie est-elle diagnostiquée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La radiothérapie n'est pas diagnostiquée, mais elle est prescrite après un diagnostic de cancer." } }, { "@type": "Question", "name": "Quels examens précèdent la radiothérapie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des examens d'imagerie comme le scanner ou l'IRM sont souvent réalisés avant la radiothérapie." } }, { "@type": "Question", "name": "Qui détermine le besoin de radiothérapie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un oncologue est responsable de l'évaluation et de la prescription de la radiothérapie." } }, { "@type": "Question", "name": "Quels types de cancers nécessitent la radiothérapie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La radiothérapie est couramment utilisée pour les cancers du sein, de la prostate et du poumon." } }, { "@type": "Question", "name": "La radiothérapie est-elle utilisée en prévention ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, la radiothérapie est un traitement curatif, pas préventif, pour les cancers diagnostiqués." } }, { "@type": "Question", "name": "Quels symptômes peuvent apparaître après la radiothérapie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, rougeur de la peau et douleurs localisées selon la zone traitée." } }, { "@type": "Question", "name": "La radiothérapie cause-t-elle des nausées ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des nausées peuvent survenir, surtout si la zone traitée est l'abdomen ou le cerveau." } }, { "@type": "Question", "name": "Y a-t-il des symptômes à long terme ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets à long terme peuvent inclure des changements cutanés ou des problèmes de fertilité." } }, { "@type": "Question", "name": "Comment gérer la fatigue liée à la radiothérapie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de se reposer, de bien s'hydrater et de suivre les conseils du médecin." } }, { "@type": "Question", "name": "La radiothérapie affecte-t-elle l'appétit ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent éprouver une perte d'appétit pendant le traitement." } }, { "@type": "Question", "name": "La radiothérapie peut-elle prévenir le cancer ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Non, la radiothérapie est un traitement, pas un moyen de prévention du cancer." } }, { "@type": "Question", "name": "Quels modes de vie aident à prévenir le cancer ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation saine, l'exercice régulier et l'évitement du tabac peuvent aider à prévenir le cancer." } }, { "@type": "Question", "name": "Les dépistages aident-ils à éviter la radiothérapie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dépistages réguliers peuvent détecter le cancer tôt, réduisant ainsi le besoin de radiothérapie." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils prévenir certains cancers ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des vaccins comme celui contre le HPV peuvent prévenir certains cancers, comme le cancer du col de l'utérus." } }, { "@type": "Question", "name": "Le stress influence-t-il le cancer ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le stress n'est pas un facteur direct, mais un mode de vie sain peut aider à réduire le risque." } }, { "@type": "Question", "name": "Quels types de radiothérapie existent ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux types sont la radiothérapie externe et la radiothérapie interne (curiethérapie)." } }, { "@type": "Question", "name": "La radiothérapie est-elle combinée à d'autres traitements ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est souvent combinée avec la chimiothérapie ou la chirurgie pour une efficacité accrue." } }, { "@type": "Question", "name": "Combien de séances de radiothérapie sont nécessaires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le nombre de séances varie selon le type de cancer, généralement entre 5 et 30 séances." } }, { "@type": "Question", "name": "La radiothérapie est-elle douloureuse ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Non, la radiothérapie elle-même n'est pas douloureuse, mais des effets secondaires peuvent l'être." } }, { "@type": "Question", "name": "Comment se déroule une séance de radiothérapie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le patient est positionné sur une table, et des rayons ciblés sont administrés sans douleur." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la radiothérapie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des lésions tissulaires, des infections et des effets secondaires à long terme." } }, { "@type": "Question", "name": "La radiothérapie peut-elle causer des cancers secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il existe un risque faible de développer des cancers secondaires après une radiothérapie." } }, { "@type": "Question", "name": "Comment prévenir les complications de la radiothérapie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et le respect des recommandations du médecin aident à prévenir les complications." } }, { "@type": "Question", "name": "Les complications varient-elles selon le type de cancer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent varier selon la localisation et le type de cancer traité." } }, { "@type": "Question", "name": "Quels soins sont nécessaires après la radiothérapie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des soins de la peau, une bonne hydratation et un suivi médical sont essentiels après le traitement." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour le cancer traité par radiothérapie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'exposition à des substances cancérigènes et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le besoin de radiothérapie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de cancer augmente avec l'âge, ce qui peut nécessiter une radiothérapie." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils la radiothérapie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de cancer ou de radiothérapie peuvent influencer le traitement futur." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle dans le traitement par radiothérapie ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines cancers sont plus fréquents chez un sexe, influençant ainsi le besoin de radiothérapie." } }, { "@type": "Question", "name": "L'alimentation affecte-t-elle le risque de cancer ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en fruits et légumes peut réduire le risque de certains cancers." } } ] } ] }

Sous-catégories

21 au total
└─

Curiethérapie

Brachytherapy D001918 - E02.815.150
└─

Chimioradiothérapie

Chemoradiotherapy D059248 - E02.815.160
└─

Irradiation crânienne

Cranial Irradiation D016371 - E02.815.190
└─

Irradiation craniospinale

Craniospinal Irradiation D061888 - E02.815.230
└─

Radiothérapie par ions lourds

Heavy Ion Radiotherapy D063193 - E02.815.250
└─

Irradiation hémicorporelle

Hemibody Irradiation D017619 - E02.815.270
└─

Irradiation ganglionnaire

Lymphatic Irradiation D015182 - E02.815.350
└─

Radioimmunothérapie

Radioimmunotherapy D016499 - E02.815.520
└─

Radiothérapie adjuvante

Radiotherapy, Adjuvant D018714 - E02.815.600
└─

Dosimétrie en radiothérapie

Radiotherapy Dosage D011879 - E02.815.639
└─

Radiothérapie de haute énergie

Radiotherapy, High-Energy D011882 - E02.815.722
└─

Radiothérapie guidée par l'image

Radiotherapy, Image-Guided D061089 - E02.815.768
└─

Radiothérapie X

X-Ray Therapy D014964 - E02.815.907
└─└─

Chimioradiothérapie adjuvante

Chemoradiotherapy, Adjuvant D059186 - E02.815.160.500
└─└─

Irradiation hypophysaire

Pituitary Irradiation D010910 - E02.815.190.600
└─└─

Protonthérapie

Proton Therapy D061766 - E02.815.250.500
└─└─

Fractionnement de la dose d'irradiation

Dose Fractionation, Radiation D019583 - E02.815.639.200
└─└─

Thérapie par capture de neutrons

Neutron Capture Therapy D017247 - E02.815.722.500
└─└─

Télégammathérapie

Radioisotope Teletherapy D011867 - E02.815.722.820
└─└─└─

Hypofractionnement de dose

Radiation Dose Hypofractionation D000069473 - E02.815.639.200.500
└─└─└─

Thérapie par capture de neutrons par le bore

Boron Neutron Capture Therapy D016754 - E02.815.722.500.100

Sources (10000 au total)

Comprehensive Implementation of Shared Decision Making in a Neuromedical Center Using the SHARE TO CARE Program.

SHARE TO CARE (S2C) is a comprehensive, multi-module implementation program for shared decision making (SDM). It is currently applied at the University Hospital Schleswig-Holstein in Kiel, Germany, an... The S2C program consists of four combined intervention modules: 1) multimodal training of physicians; 2) a patient activation campaign including the ASK-3 method; 3) digital evidence-based patient dec... Eighty-nine percent of all physicians (N = 56) completed the SDM training. We developed a total of 12 evidence-based digital decision aids in the center, educated two decision coaches to support patie... The S2C program has been successfully implemented within the entire Neuromedical Center. Patients reported a medium to small increase of perceived involvement in decision making demonstrating the effe...

Feasibility of an Individualized Dispensing Program for Patients Prescribed Oral Anticancer Drugs to Prevent Waste.

Waste of oral anticancer drugs (OACDs) causes financial and environmental burdens. This study evaluates the feasibility of an individualized dispensing program to prevent waste of OACDs.... Adult patients were dispensed individualized quantities of niraparib, abiraterone, enzalutamide, ruxolitinib, osimertinib, or imatinib as standard care, during the first 6 months of treatment. The fir... Participants' median age was 67 (interquartile range [IQR], 58-71) years, and 76% was male. (1)... Individualized dispensing for patients prescribed OACDs is feasible for preventing waste in terms of implementation, acceptability, practicality, effect, and demand....

Pan-Canadian caregiver experiences in accessing government disability programs: A mixed methods study.

At present, little is known about the factors that contribute to the relatively low uptake of government-funded disability programs in Canada.... Understand how parents/caregivers of Canadian youth with neurodevelopmental disability (NDD) experience the process of applying for and accessing disability programs.... This mixed methods sequential explanatory study utilized two phases: an online survey (quantitative), followed by semi-structured interviews (qualitative). The quantitative phase gathered sociodemogra... 499 participants completed the online survey and 81 participants completed an interview. Analysis of survey data revealed that many participants are not accessing disability programs and experience di... The results of this study highlight policy changes that are needed to ensure disability programs adequately support Canadian families....